Industry News
Tool to delete DNA
A Canadian team has developed a new method using the Cre/loxP recombination system to delete chromosome regions in embryonic stem cells. [ + ]
Web-based genomics computational resource facilitates research
Researchers from Cincinnati Children's Hospital Medical Center and the University of Cincinnati (UC) Academic Health Center at the Computational Medicine Center have established a gene information resource designed to aid biomedical researchers in more effectively identifying small alterations in the human genome that are associated with individuals' susceptibility to disease.
[ + ]CRCA announces CEO
Michael Hartmann has commenced his role as chief executive officer of the Cooperative Research Centres Association (CRCA).
[ + ]Cruelty-free testing for insulin
Scientists and physicians with the Physicians Committee for Responsible Medicine (PCRM) have outlined a method used to develop a cruelty-free ELISA (enzyme-linked immunosorbant assay) for human insulin that uses monoclonal antibodies produced by cells cultured in an animal-serum-free medium.
[ + ]Rhomboids give biological heresy a cold shower
Four years ago Matthew Freeman discovered the first of a new family of membrane-active protease enzymes, rhomboids. They disturbed the sleep of biophysicists, but are now inspiring drug researchers to dream. [ + ]
Proteins while you wait
The need for high-throughput methods for rapid, larger scale purification and production of recombinant proteins is a major challenge for biomedical research. A team from Monash University is taking that challenge. [ + ]
Steps on the road to the Holy Grail
The publication of the molecular structure of the insulin receptor last September, led by Australia's Colin Ward, was a milestone in the life sciences. Fiona Wylie profiles the man behind the receptor. [ + ]
Apollo gets ready for lift-off
Successful toxicology trials means Apollo Life Science can move towards human clinical trials for its insulin in tablet form. [ + ]
CMRI looks at p53 and Rett Syndrome
The Children's Medical Research Institute in Sydney has set up a new unit to look at the p53 tumour suppressor gene, and one of its young scientists has received further funding for his research into Rett Syndrome. [ + ]
Insulin xenotransplantation trial gets go ahead
Australian biotech Living Cell Technologies (LCT) has been given the green light to start a xenotransplantation trial in diabetic patients in Russia. [ + ]
Phylogica's pipeline expansion
West Australian biotech Phylogica has appointed former Pharmaxis scientist Dr Doug Francis to head its drug development team. [ + ]
Ultrasensitive optical sensor detects viruses fast
Scientists of the Biophysical Engineering Group of the University of Twente in The Netherlands have developed an ultrasensitive sensor that can be used in a handheld device to, within minutes, detect various viruses and measure their concentration.
[ + ]Canada completes human metabolome first draft
Canadian researchers have completed the first draft of the human metabolome. [ + ]
Blood pressure drug reverses muscle wasting in mice
A drug commonly used to lower blood pressure can prevent muscle degeneration and even reverse muscle wasting in genetically engineered mice. [ + ]
Australian students given opportunity to create sustainable future
A program launched by Nespresso Australia will see a local student travelling to Costa Rica to discover how to create a more sustainable future.
[ + ]